home Laboratory Introduction

Daebong LS laboratory
continuously promotes
innovation in order to meet the future needs of
customers and enable them to lead
healthy and beautiful lives

Daebong LS Laboratory seeks
to stay ahead of the competition
and promote healthier and more beautiful lives.

Advanced products developed by Daebong LS Labs are being distributed both domestically and globally to various countries
including Japan and throughout Southeast Asia, Central and South America and Europe. We are dedicated to maintaining
high quality levels and developing better products.

History

  • 2018

    Journal of Dermatological Science 2018 ; DESC 3370 No. of pages 11, ‘Methyl-2-acetylamino-3-(4-hydroxyl-3,5-dimethoxybenzoylthio)propanoate suppresses

    melanogenesis through ERK signaling pathway mediated MITF proteasomal degradation’ Presentation

    31th IFSCC Congress 2018, ‘Effect of Coated White Jade powder on Cytotoxic and Oxidative Stress induced by Heavy Metals( Cd, Pb)’ Presentation In-Cosmetic Asia 2018, ‘Effect and safety study of new materials using fermented Cysteine’ Presentation

  • 2017

    Life Science 191 (2017) 52-58, ‘An inhibitory mechanism of action of a novel syringic-acid derivative on α-melanocyte-stimulating hormone(α-MSH)-induced melanogenesis’ Presentation

    Bull. Korean Chem, Soc. 2017, Vol.38, 78-84, ‘Synthesis, Antioxidative and Whitening Effects of Novel Cysteine Derivatives’ Presentation

    30th IFSCC Congress 2017, ‘Anti-inflammatory and Anti-oxidative Effect of Purified Jeju Horse Fat in Human Keratinocyte and Macrophage’

    •‘A novel benzoylsulfanylacetylcysteine derivative, DBLS-24, suppresses melanogenesis through activation of ERK signaling pathway’•’Synthesis and Evaluation of Tocopherol derivatives and Pseudo ceramide as a Cosmeceutical ingredients’ Presentation

  • 2016

    In-Cosmetics Korea, received the 'IBITA Innovative & Creative Raw Material Producer' Award for natural cosmetics ingredients technology

    Established the Daebong LS Jeju factory (opened Jeju factory)

    Expansion of the Jeju Natural Products Laboratory
    (Jeju Techno Park → Advanced Science and Technology Park)

  • 2014

    Daebong LS registered as the Jeju Natural Products Laboratory (Korea Industrial Technology Association)

    Received award as 'BEST Beauty Innovator' at the 13th World Hanseong Convention for Natural Cosmetic ingredients Technology

  • 2013

    Daebong LS registered as the Incheon Natural Products Laboratory (Korea Industrial Technology Association)

    Establishment of the Jeju Natural ingredients Application Research Institute

  • 2011 ~ 2012

    (Olmesartan medoxomill) added to Hypertension treatment

    Development of raw cosmetic materials (TES Triolears)

    Selected to promote Jeju Metropolitan Economic Area and Industries

    Participated in project to upgrade eco-friendly biomaterials (3G-Bio related)

  • 2009 ~ 2010

    Selected as an on-site project for the Korea Industrial Complex Corporation

    Development of hypertension treatment (Valsartan, Amlodipine besylate).
    Development of functional cosmetic raw ingredients synthesis

    Development of a new extract of Rubus coreanus root (Product name: Prorelief LS-1)

    Incheon Natural Products Laboratory established

  • 2006 ~ 2008

    Selected as a joint core projects by Korea’s Ministry of Knowledge and Economy including (development of PioglitazoneHCL process for diabetes treatment), development of solvents (Itopride HCL, Mosarpride citrate), development of contrast agent (lodixanol, lohexol, lopamidol)

    Development of rosiglitazone (Rosiglitazone) (Patent No. 100697982)

    Preparation method and development of a pharmaceutical composition (pioglitazone) containing crystalline polymorphism of pioglitazone potassium salt (Patent No. 100697983)

  • 2004 ~ 2005

    Synthesis of Acebrophyline for Asthma and Chronic Obstructive Disease

    Development of thioctic acid for diabetic polyneuritis, synthesis of Losartan potassium for hypertension

    Development of permanent-wave substance (monoethanolamine thiolactate 63%)

    Development of one-formulation oxidative permanent hair dye paste. (Patent No. 100443021)

  • 2000~2003

    Daebong LS registered as the Convergence Technology Laboratory (Korea Industial Technology Association)

    Synthesis of Ticlopidine.HCI, Aceplifyline and erdosteine for bronchial asthma

    Synthesis of Piroxicam Potassium Injection

    Synthesis of antifungal agent (Terbinerfine.HCI)

    BGMP certification obtained

    Synthesis of Prednisolone 21-Stearoylglycolate

  • 1980~1999

    Development of permanent-wave substance (Thiomin, ATG, L-Cysteine.HCI.H2O, L-Cystine Free-base, DL-Cysteine.HCI.H20)

    Synthesis of L-Cystine, S-Carboxymethylcysteine and N-Acetyl-L-cysteine

    Established Daebong LS Labortory(Began as a research team for raw materials development)

    Completion of GMP factory in Gojan-dong, Namdong-gu, Incheon city and relocation of headquarters

    Manufacture of high concentration neutralizing agent (Patent No. 20168) Development of 4 EMOL brand products by increasing the 40 products in development to 150 products

    First hair science book in Korea

    Moved Mid-East factory to Bucheon city in Gyeonggi province, Production of Ammonium thioglycolate (Patent No. 16456)

    Established 'Hanjin Fine Chemical' in Songnae-dong, Bucheon, Gyeonggi province and produced sodium bromate (Patent No.10101)

Research Project History

  • 2018.11.07~2020.11.06

    Development of QbD model-based medicines and business models utilizing domestic development raw materials(Development of diabetes treatment drug which is difficult to control blood sugar by monotherapy)

  • 2018.04.01~2020.12.31

    Development of sensitive skin improvement cosmetics using natural ingredients and biotechnology

  • 2018.04.01~2020.12.31

    Development of moisturizing functional cosmetics for atopy using smart farm cultivated crops and development of anti-aging biotechnology materials using beneficial microorganisms derived from Jeju

  • 2017.06.01~2018.05.31

    Development of the drug L-Carbocysteine, which is a bronchial mucolytic agent, starting from L-Cysteine, a cosmetic material.

  • 2015.10.01~2016.09.30

    Development of functional cosmetic ingredients from clove derivatives

  • 2014.12.01~2015.11.30

    Anti-Aging Cosmetics Development Theme Cluster Project

  • 2014.07.01~2015.06.30

    Global Cosmetics Theme Cluster Project

  • 2013.12.01~2014.04.26

    Personnel advancement project for research and development of Nagoya Protocol correspondence window

  • 2012.06.01~2015.04.30

    Leading industry of Jeju metropolitan economy

  • 2012.02.01~2015.12.31

    15th agenda research and development project

  • 2011.12.01~2013.11.30

    Regional industrial technology development business

  • 2011.07.01~2014.04.30

    Jeonnam Regional Economic Cooperation Project

  • 2011.06.01~2013.12.31

    Practical use of agricultural products

  • 2011.03.01~2011.12.31

    Regional agricultural specialization technology development business

  • 2011.02.01~2014.10.31

    Global Cosmetic Research and Development Project

  • 2009.12.23~2010.12.22

    Manufacturing process development of Olmesartan Medoxomil which is a derivative on Biphenyl tetrazole for hypertension treatment